Aim: to review and analyze the use of gonadotropin-releasing hormone (GnRH) antagonists in endometriosis, adenomyosis, non-menstrual pelvic pain, uterine fibroids, prostate cancer, female infertility, precocious puberty. Methods: information used write this manuscript was obtained during a three-month period, between October May 2022, from specialized literature, written English Spanish, relate...

Background: Male factors, mainly spermatogenesis disorder, are responsible for 20 – 30% of infertility ocuurs in different societies. One of the known causes of spermatogenesis disorder is chemotherapy in patients with cancer. The side effect of chemoterpic agents may last from 10 years up to the end of the life. Since dividing cells are mainly affected by anticancer drugs, the aim of the prese...

Clinical outcomes of dual trigger containing gonadotropin-releasing hormone agonist (GnRHa) and low dose human chorionic gonadotropin (hCG) compared with the standard for final oocyte maturation in normal responder patients GnRH Antagonist IVF-ICSI Cycles. A single centre prospective randomized comparative study conducted at a tertiary care infertility , Akanksha IVF centre, Janakpuri, New Delh...